| Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad Advanced drug delivery reviews 66, 2-25, 2014 | 3185 | 2014 |
| Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release N Kamaly, B Yameen, J Wu, OC Farokhzad Chemical reviews 116 (4), 2602-2663, 2016 | 2821 | 2016 |
| Targeted polymeric therapeutic nanoparticles: design, development and clinical translation N Kamaly, Z Xiao, PM Valencia, AF Radovic-Moreno, OC Farokhzad Chemical Society Reviews 41 (7), 2971-3010, 2012 | 1937 | 2012 |
| Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery N Habibi, N Kamaly, A Memic, H Shafiee Nano today 11 (1), 41-60, 2016 | 637 | 2016 |
| Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation J Shi, Z Xiao, N Kamaly, OC Farokhzad Accounts of chemical research 44 (10), 1123-1134, 2011 | 549 | 2011 |
| Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle MA Miller, S Gadde, C Pfirschke, C Engblom, MM Sprachman, RH Kohler, ... Science translational medicine 7 (314), 314ra183-314ra183, 2015 | 359 | 2015 |
| Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice G Fredman, N Kamaly, S Spolitu, J Milton, D Ghorpade, R Chiasson, ... Science translational medicine 7 (275), 275ra20-275ra20, 2015 | 359 | 2015 |
| Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair G Leoni, PA Neumann, N Kamaly, M Quiros, H Nishio, HR Jones, ... The Journal of clinical investigation 125 (3), 1215-1227, 2015 | 328 | 2015 |
| Engineered nanomedicine for myeloma and bone microenvironment targeting A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ... Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014 | 305 | 2014 |
| Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles N Kamaly, G Fredman, M Subramanian, S Gadde, A Pesic, L Cheung, ... Proceedings of the National Academy of Sciences 110 (16), 6506-6511, 2013 | 240 | 2013 |
| Nanomedicines for renal disease: current status and future applications N Kamaly, JC He, DA Ausiello, OC Farokhzad Nature Reviews Nephrology 12 (12), 738-753, 2016 | 233 | 2016 |
| Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis N Kamaly, G Fredman, JJR Fojas, M Subramanian, WII Choi, K Zepeda, ... ACS nano 10 (5), 5280-5292, 2016 | 211 | 2016 |
| CXCR4‐targeted and MMP‐responsive iron oxide nanoparticles for enhanced magnetic resonance imaging J Gallo, N Kamaly, I Lavdas, E Stevens, QD Nguyen, ... Angewandte Chemie International Edition 53 (36), 9550-9554, 2014 | 181 | 2014 |
| Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging N Kamaly, T Kalber, M Thanou, JD Bell, AD Miller Bioconjugate chemistry 20 (4), 648-655, 2009 | 174 | 2009 |
| Development of multinuclear polymeric nanoparticles as robust protein nanocarriers J Wu, N Kamaly, J Shi, L Zhao, Z Xiao, G Hollett, R John, S Ray, X Xu, ... Angewandte Chemie International Edition 53 (34), 8975-8979, 2014 | 165 | 2014 |
| Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging N Kamaly, T Kalber, A Ahmad, MH Oliver, PW So, AH Herlihy, JD Bell, ... Bioconjugate Chemistry 19 (1), 118-129, 2008 | 160 | 2008 |
| Targeted nanoparticles for colorectal cancer BA Cisterna, N Kamaly, WI Choi, A Tavakkoli, OC Farokhzad, C Vilos Nanomedicine 11 (18), 2443-2456, 2016 | 159 | 2016 |
| Direct synthesis of dextran-coated superparamagnetic iron oxide nanoparticles in a capillary-based droplet reactor K Kumar, AM Nightingale, SH Krishnadasan, N Kamaly, ... Journal of Materials Chemistry 22 (11), 4704-4708, 2012 | 132 | 2012 |
| Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo GD Kenny, N Kamaly, TL Kalber, LP Brody, M Sahuri, E Shamsaei, ... Journal of Controlled Release 149 (2), 111-116, 2011 | 121 | 2011 |
| DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA M Mével, N Kamaly, S Carmona, MH Oliver, MR Jorgensen, C Crowther, ... Journal of Controlled Release 143 (2), 222-232, 2010 | 120 | 2010 |